Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Altek Interim / Quarterly Report 2013

Aug 9, 2013

52290_rns_2013-08-09_8921c498-ab66-4d7d-bce8-95b1b5984b7e.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

2013 Q2 Investor Conference August 9, 2013

1

13Q2 IS Highlights

  • Net Sales: 21% increase from last quarter

  • Lower than guidance in last conference due to global DSC shipment declined beyond of expectation.

  • Gross Profit %: 6.4%, declined 0.2% on a QoQ basis

  • Product mix changed.

  • OPEX %: 6.3%, down 1.8% compared to Q1

  • Continuously control expenses.

  • EPS: NT$0.04

Note: The 13Q2 figures are audited.

2

Consolidated Income Statements

Unit: NT$ millions (Except EPS: NT$), %

Year 13Q2 13Q2 13Q1 13Q1 QoQ
Item Amount % Amount % %
Net Sales 4,854 100.0 4,014 100.0 20.9
Cost of Goods Sold (4,544) (93.6) (3,748) (93.4) 21.2
Gross Profit 310 6.4 266 6.6 16.5
Operating Expenses (305) (6.3) (326) (8.1) (6.6)
Operating Profit 5 0.1 (60) (1.5) (108.3)
Non-Operating Gain 12 0.2 15 0.4 (19.0)
Profit before Income Tax 17 0.3 (46) (1.1) (137.0)
Income Tax Expense (1) (0.0) 0 0.0 #DIV/0!
Net Profit 16 0.3 (46) (1.1) (135.9)
Basic EPS (after tax) 0.04 (0.12)

Note: 1. Weighted‐average outstanding common shares of 13Q2 were 375,264 thousand shares

  1. Amount and percentage numbers were calculated on the NT$ thousand basis from audited financial statements

3

Consolidated Income Statements(Cont.)

Unit: NT$ millions (Except EPS: NT$), %

Year 13H1 13H1 12H1 12H1 YoY
Item Amount % Amount % %
Net Sales 8,867,835 100.0 13,421,167 100.0 (33.9)
Cost of Goods Sold (8,292,482) (93.5) (12,465,333) (92.9) (33.5)
Gross Profit 575,353 6.5 955,834 7.1 (39.8)
Operating Expenses (631,202) (7.1) (841,695) (6.3) (25.0)
Operating Profit (55,849) (0.6) 114,139 0.9 (148.9)
Non-Operating Gain 26,665 0.3 93,687 0.7 (71.5)
Profit before Income Tax (29,184) (0.3) 207,826 1.5 (114.0)
Income Tax Expense (513) (0.0) (35,018) (0.3) (98.5)
Net Profit (29,697) (0.3) 172,808 1.3 (117.2)
Basic EPS (after tax) (0.08) 0.46

4

13.6.30 BS & CF Highlights

� Cash & Marketable Securities: NT$ 5,380M

  • Debt Ratio: 45.6%, Current Ratio: 158%

� Notes & AR / Notes & AP : NT$ 3,612M / NT$ 5,057M

  • Inventories: NT$ 2,569M

  • BPS: NT$ 27.02

Note: The 13Q2 figures are audited.

5

Consolidated BS & CF Highlights

Unit: NT$ millions, %

Year 13.6.30 13.6.30 13.3.31 13.3.31
Item Amount % Amount %
Cash & Marketable Securities 5,380 29 5,260 32
Notes & accounts receivables,net 3,612 19 2,627 16
Inventories 2,569 14 1,819 11
Property,Plant and Equipment 5,633 30 5,488 33
TOTAL ASSETS 18,715 100 16,566 100
Bank loan 450 2 250 2
Notes & accountspayable 5,057 27 2,957 18
TOTAL LIABILITIES 8,529 46 6,179 37
Common Stock 3,961 21 3,961 24
Retain Earnings 4,783 26 4,883 29
TOTAL EQUITY 10,186 54 10,308 62
Year 13Q2 13Q1
Item Amount % Amount %
Net Cash Provided byOperatingActivities (24) (22)

Note: 1. Outstanding common shares as of 13.6.30 were 377,015 thousand shares

  1. Amount and percentage numbers were calculated on the NT$ thousand basis from audited financial statements

6

Q&A Session

7

Safe Harbor Notice

We have made forward-looking statements in the presentation. Our forward-looking statements contain information regarding, among other things, our financial conditions, future expansion plans and business strategies. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that these expectations and projections are reasonable, such forward-looking statements are inherently subject to risks, uncertainties, and assumptions about us.

We undertake no obligation to publicly update or revise any forwardlooking statements whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events in the conference might not occur and our actual results could differ materially from those anticipated in these forward-looking statements.

8